Trial to Optimally Show the Pharmacological Action of Z-100
The objective of this clinical trial is to evaluate the change of the immunological parameter levels in FIGO stage IIIB cervical cancer subjects by administration of Z-100
Cervical Cancer
DRUG: Z-100|DRUG: Placebos
Change in the number of immunological cells, 2 years
Overall survival, 3 years|Disease-specific survival, 2 years|Recurrence-free survival, 3 years|Rate of adverse events/adverse drug reactions, 2 years
The objective of this clinical trial is to evaluate the change of the immunological parameter levels in FIGO stage IIIB cervical cancer subjects by administration of Z-100